Sort

Search

01/06/2026 Artificial Intelligence-Assisted reflectance confocal microscopy for Real-Time intraoperative margin assessment in oral squamous cell carcinoma
Hosseinzadeh, F, Zanoni, D, França, PDD, Valero, C, Peterson, G, Ardigo, M, Ghossein, R, Dusza, SW, Pillarsetty, N, Kose, K, Wong, RJ, Ganly, I, Rajadhyaksha, M, Patel, SG. Artificial Intelligence-Assisted reflectance confocal microscopy for Real-Time intraoperative margin assessment in oral squamous cell carcinoma. ORAL ONCOLOGY. 2026; 177DOI:10.1016/j.oraloncology.2026.107939. PMID:41932031. IF:3.900(Q1/2D).
01/06/2026 Pomalidomide, Cyclophosphamide and Dexamethasone (PCd): Outcomes in Patients With Double- or Triple-Refractory Multiple Myeloma
Hidalgo-Soto, M, Rodríguez-Lobato, LG, Borrella, CM, Cayuela, AS, Pardo, JL, Rosiñol, L, Cibeira, MT, García-Guiñon, A, Tolosa-Ridao, C, Arostegui, IC, Sureda, A, Herranz, MJ, Montreal, EA, Pelicano, M, Alzuria, YB, Sansa, MC, Gironella, M, González, Y, De Larrea, CF. Pomalidomide, Cyclophosphamide and Dexamethasone (PCd): Outcomes in Patients With Double- or Triple-Refractory Multiple Myeloma. EUROPEAN JOURNAL OF HAEMATOLOGY. 2026; 116(6)DOI:10.1111/ejh.70126. PMID:41652820. IF:2.300(Q2/5D).
01/06/2026 Advancing the Treatment of Motor Fluctuations in Parkinson's Disease with a Next-Generation Levodopa/Carbidopa Formulation
Stocchi, F, Knecht, M, Marjanovic, I, Wach, A, Kopra, J, Kulisevsky, J. Advancing the Treatment of Motor Fluctuations in Parkinson's Disease with a Next-Generation Levodopa/Carbidopa Formulation. Neurology and Therapy. 2026; 15(3)DOI:10.1007/s40120-026-00898-z. PMID:41724884. IF:4.800(Q1/2D).
01/06/2026 Next generation sequencing approaches for the detection and characterization of enteroviruses in clinical, public health, and research settings: Expert view of the European non-polio enterovirus network (ENPEN)
Benschop, KSM, Zwagemaker, F, Andersson-Li, L, Andrés, C, Antón, A, Berengua, C, Berginc, N, Bessaud, M, Bisseux, M, Bujaki, E, Canning, B, Christiansen, CB, Couderé, K, Broberg, EK, Cassidy, H, Castilletti, C, Celma, C, Cinek, O, Deézsi-Magyar, N, Eis-Hübinger, AM, Flipse, J, Jirincová, H, Gatej, R, Georgieva, I, Giardina, F, González-Sánchez, A, Hack, B, Helfferich, J, Hutchings, S, Hietanen, E, Hönemann, M, Virant, MJ, Kalogera, E, Johannesen, CK, Kenicer, J, Kleines, M, Lagarejos, E, Landaas, ET, Kandulu, CC, Labrador, FXL, Lunar, MM, Maier, M, Majumdar, M, Martin, J, McClure, CP, Muñoz-Almagro, C, Osep, A, Overbo, J, Palminha, P, Papa, A, Pariani, E, Pellegrinelli, L, Pietsch, C, Piralla, A, Poljak, M, Pomari, E, Prats-Méndez, I, Rector, A, Reuter, G, Riess, M, Ruta, S, Schibler, M, Nilsen, HJS, Simmonds, P, Sourvinos, G, Szomor, K, Susi, P, Tabain, I, Vallely, P, von Eije, KJ, Weil, M, Wieczorek, M, Wollants, E, Wolthers, KC, Zuckerman, NS, Fischer, TK, Harvala, H. Next generation sequencing approaches for the detection and characterization of enteroviruses in clinical, public health, and research settings: Expert view of the European non-polio enterovirus network (ENPEN). JOURNAL OF CLINICAL VIROLOGY. 2026; 184DOI:10.1016/j.jcv.2026.105940. PMID:41905022. IF:3.400(Q2/5D).
01/06/2026 Clinical Factors Associated With Current Relevance in Allergic Contact Dermatitis: Development of Predictive Models Based on Data From the Spanish Contact Dermatitis Register (REIDAC)
Pesqué, D, de Frutos, FJO, Navarro-Triviño, F, Sanz-Sánchez, T, Zaragoza-Ninet, V, Córdoba-Guijarro, S, Miquel-Miquel, J, Silvestre-Salvador, JF, González-Pérez, R, Ruiz-González, I, Mercader-García, P, Serra-Baldrich, E, Carrascosa-Carrillo, JM, Tous-Romero, F, Rodríguez-Serna, M, Gatica-Ortega, ME, Paredes-Suárez, C, Pastor-Nieto, MA, Chicharro, P, Andreu, M, Sánchez-Gilo, A, Pereyra-Rodríguez, JJ, Melé-Ninot, G, Guillén, PS, de la Fuente, EG, Elosua-González, M, Gallardo, F, Pujol, RM, García-Doval, I, Borrego, L, Descalzo, MA, Giménez-Arnau, AM. Clinical Factors Associated With Current Relevance in Allergic Contact Dermatitis: Development of Predictive Models Based on Data From the Spanish Contact Dermatitis Register (REIDAC). CONTACT DERMATITIS. 2026; 94(6)DOI:10.1111/cod.70089. PMID:41714111. IF:4.600(Q1/1D).
01/06/2026 Real-World Effectiveness and Safety of Lebrikizumab in Moderate-to-Severe Atopic Dermatitis: A Multicenter Study From Spain
Armario-Hita, JC, Galán-Gutierrez, M, Pereyra-Rodríguez, JJ, Suarez-Pérez, J, Rodríguez-Serna, M, de Frutos, JO, Carrascosa, JM, Serra-Baldrich, E, Figueras-Nar, I, Zaragoza-Ninet, V, Ruiz-Villaverde, R. Real-World Effectiveness and Safety of Lebrikizumab in Moderate-to-Severe Atopic Dermatitis: A Multicenter Study From Spain. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2026; 65(6)DOI:10.1111/ijd.70185. PMID:41310412. IF:3.200(Q1/3D).